Emergent Biosolutions EBS Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Total revenues by Business | |||||
| Commercial Products | $226.1M-43.3% | $398.9M-19.8% | $497.3M+28.6% | $386.6M-11.7% | |
| MCM Products | $456.7M-10.4% | $509.8M+14.0% | $447.2M-22.8% | $579.6M-1.1% | |
| Total revenues by Product | |||||
| All other revenue | $60.1M-55.4% | $134.9M+28.7% | $104.8M— | —— | |
| Commercial Product sales | $226.1M-43.3% | $398.9M-19.8% | $497.3M+28.6% | $386.6M-11.7% | |
| MCM Product sales | $456.7M-10.4% | $509.8M+14.0% | $447.2M-22.8% | $579.6M-1.1% | |
| Total revenues by Geography | |||||
| Canada | $75M-46.6% | $140.4M-37.4% | $224.2M+50.9% | $148.6M+123% | |
| Other | $136.8M+69.7% | $80.6M-63.0% | $217.9M+163% | $82.8M-0.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Emergent Biosolutions break its business down?
- Emergent Biosolutions (EBS) reports total revenues by business across 2 parts — Commercial Products and MCM Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Emergent Biosolutions's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Emergent Biosolutions's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
